BNP Paribas Financial Markets’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,505
| Closed | -$17.7K | – | 3332 |
|
2022
Q4 | $17.7K | Sell |
1,505
-1,565
| -51% | -$18.4K | ﹤0.01% | 2898 |
|
2022
Q3 | $65K | Buy |
3,070
+1,481
| +93% | +$31.4K | ﹤0.01% | 3208 |
|
2022
Q2 | $38.5K | Buy |
1,589
+1,074
| +209% | +$26K | ﹤0.01% | 2975 |
|
2022
Q1 | $25.6K | Sell |
515
-791
| -61% | -$39.4K | ﹤0.01% | 3117 |
|
2021
Q4 | $91.7K | Buy |
1,306
+191
| +17% | +$13.4K | ﹤0.01% | 2980 |
|
2021
Q3 | $104K | Buy |
1,115
+796
| +250% | +$74.3K | ﹤0.01% | 2672 |
|
2021
Q2 | $32K | Sell |
319
-701
| -69% | -$70.4K | ﹤0.01% | 2814 |
|
2021
Q1 | $95.2K | Buy |
1,020
+248
| +32% | +$23.1K | ﹤0.01% | 2821 |
|
2020
Q4 | $63.7K | Sell |
772
-764
| -50% | -$63K | ﹤0.01% | 2790 |
|
2020
Q3 | $132K | Buy |
1,536
+1,109
| +260% | +$95.2K | ﹤0.01% | 2365 |
|
2020
Q2 | $39.7K | Sell |
427
-1,151
| -73% | -$107K | ﹤0.01% | 2519 |
|
2020
Q1 | $45K | Buy |
1,578
+600
| +61% | +$17.1K | ﹤0.01% | 2981 |
|
2019
Q4 | $40.5K | Buy |
978
+853
| +682% | +$35.3K | ﹤0.01% | 3090 |
|
2019
Q3 | $1.77K | Buy |
125
+101
| +421% | +$1.43K | ﹤0.01% | 3732 |
|
2019
Q2 | $856 | Buy |
24
+9
| +60% | +$321 | ﹤0.01% | 3749 |
|
2019
Q1 | $866 | Hold |
15
| – | – | ﹤0.01% | 3562 |
|
2018
Q4 | $741 | Buy |
15
+2
| +15% | +$99 | ﹤0.01% | 3281 |
|
2018
Q3 | $920 | Hold |
13
| – | – | ﹤0.01% | 3651 |
|
2018
Q2 | $1.05K | Sell |
13
-215
| -94% | -$17.3K | ﹤0.01% | 3644 |
|
2018
Q1 | $23.9K | Sell |
228
-9
| -4% | -$943 | ﹤0.01% | 3296 |
|
2017
Q4 | $30.4K | Buy |
237
+166
| +234% | +$21.3K | ﹤0.01% | 3204 |
|
2017
Q3 | $8.15K | Sell |
71
-5
| -7% | -$574 | ﹤0.01% | 3350 |
|
2017
Q2 | $9.89K | Buy |
+76
| New | +$9.89K | ﹤0.01% | 3368 |
|